Interferon-Alpha With Or Without Rituximab Achieves a High Response Rate and Durable Responses In Relapsed FL: 17 years' Experience In a Single Centre

被引:0
|
作者
Radesi-Sarghi, Sinziana
Arbion, Flavie
Dartigeas, Caroline
Delain, Martine
Benboubker, Lotfi
Herault, Olivier
Colombat, Philippe
Gyan, Emmanuel
机构
关键词
D O I
10.1182/blood.V122.21.5126.5126
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5126
引用
收藏
页数:1
相关论文
共 4 条
  • [1] Interferon alpha with or without rituximab achieves a high response rate and durable responses in relapsed FL: 17 years’ experience in a single centre
    Sinziana Radesi-Sarghi
    Flavie Arbion
    Caroline Dartigeas
    Martine Delain
    Lotfi Benboubker
    Olivier Hérault
    Philippe Colombat
    Emmanuel Gyan
    Annals of Hematology, 2014, 93 : 147 - 156
  • [2] Interferon alpha with or without rituximab achieves a high response rate and durable responses in relapsed FL: 17 years' experience in a single centre
    Radesi-Sarghi, Sinziana
    Arbion, Flavie
    Dartigeas, Caroline
    Delain, Martine
    Benboubker, Lotfi
    Herault, Olivier
    Colombat, Philippe
    Gyan, Emmanuel
    ANNALS OF HEMATOLOGY, 2014, 93 (01) : 147 - 156
  • [3] High dose therapy/ASCT consolidated with rituximab and or alpha interferon immunotherapy for relapsed follicular lymphoma prolongs progression free survival and achieves durable molecular remissions.
    Buckstein, RJ
    Mangel, J
    Imrie, K
    Spaner, D
    Crump, M
    Pennell, N
    Boudreau, A
    Reis, M
    Robinson, J
    Romans, R
    Richardson, P
    Nagy, T
    Berinstein, N
    BLOOD, 2002, 100 (11) : 647A - 648A
  • [4] Short-course pretransplant velcade, thalidomide and dexamethasone regimen induces high complete response rate without compromising CD34+cell collection in untreated multiple myeloma patients: preliminary results of a single-centre experience
    Pennese, E.
    Dargenio, M.
    De Paolis, M. R.
    Forese, P.
    Matera, R.
    Pugliese, G.
    Reddiconto, G.
    Valacca, A.
    Vergine, C.
    Di Renzo, N.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S151 - S151